Found 0 matching trials
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy PHASE2 This study is being done to see if the investigational drug, anakinra, prev...
Show More Status
Active Not Recruiting
Location
Hackensack Meridian Health (Data collection only)
Learn More & Join Trial
CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission PHASE1 This phase I trial tests the safety, side effects, and best dose of autolog...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Universal CAR-T Cells Targeting Multiple Myeloma PHASE1 The aim of this study is to assess the feasibility, safety and efficacy of ...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children PHASE1 This phase I trial investigates the side effects of chemotherapy and cellul...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma PHASE1 This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Show More Location
District One Hospital
Learn More & Join Trial
Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation PHASE1 The purpose of this study is to administer novel cluster of differentiation...
Show More Location
University College London Hospital
Learn More & Join Trial
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies PHASE1 This is a phase I, prospective clinical trial studying the safety and feasi...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL PHASE1 This is a Phase 1/1b, open-label, dose-escalation study to evaluate the saf...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
BR101 in Patients With Relapsed/Refractory Multiple Myeloma PHASE1 This study is an open-label, single-arm, dose-escalation and dose-expansion...
Show More Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL PHASE1 It is a treatment that activates and strengthens the immune system against ...
Show More Location
Acıbadem Labcell Cellular Therapy Laboratories
Learn More & Join Trial